Songporn Oranratnachai

Chiang Mai, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Enhancing Cancer Prediction Among People With Elevated CEA: A Novel Approach Using CEA Levels and Clinical Risk Scoring.

Enhancing Cancer Prediction Among People With Elevated CEA: A Novel Approach Using CEA Levels and Clinical Risk Scoring.

Journal: Journal of primary care & community health

Published: March 19, 2026

Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy.

Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy.

Journal: Translational lung cancer research

Published: February 19, 2026

Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.

Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.

Journal: Frontiers in oncology

Published: January 14, 2026

Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients.

Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients.

Journal: Lung Cancer (Auckland, N.Z.)

Published: November 03, 2025

Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital.

Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital.

Journal: Cancer medicine

Published: May 13, 2024

Long-term posttransplant survival outcome following bridging locoregional therapy in hepatocellular carcinoma patients: A systematic review and meta-analysis.

Long-term posttransplant survival outcome following bridging locoregional therapy in hepatocellular carcinoma patients: A systematic review and meta-analysis.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 21, 2024

Dynamic changes in immune repertoire profiles in patients with stage III unresectable non-small cell lung cancer during consolidation treatment with immunotherapy.

Dynamic changes in immune repertoire profiles in patients with stage III unresectable non-small cell lung cancer during consolidation treatment with immunotherapy.

Journal: BMC cancer

Published: September 05, 2023

Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.

Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.

Journal: Frontiers in oncology

Published: September 28, 2022

Treatment outcomes of advanced hepatocellular carcinoma in real-life practice: Chemotherapy versus multikinase inhibitors.

Treatment outcomes of advanced hepatocellular carcinoma in real-life practice: Chemotherapy versus multikinase inhibitors.

Journal: Cancer medicine

Published: June 22, 2022

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer.

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer.

Journal: BMC cancer

Published: March 03, 2022

Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol University.

Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol University.

Journal: Cancer reports (Hoboken, N.J.)

Published: September 29, 2021

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients.

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients.

Journal: Cancer biomarkers : section A of Disease markers

Published: April 26, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026